A new era opens for adolescent vaccines
Three new vaccines recommended for adolescents have hit the market this year. In January, the FDA approved a vaccine for meningococcal disease. Menactra, a polysaccharide conjugate vaccine (MCV4) developed by Sanofi Pasteur, is protective against four serogroups of Neisseria meningitidis. In May, the first vaccine to reinforce pertussis immunity, Boostrix (developed by GlaxoSmithKline), was approved,…
